Compare GXO Logistics Inc (GXO) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GXO Logistics Inc vs Tempus AI — how do they compare? GXO Logistics Inc trades at $46.53 (market cap $5.32B), while Tempus AI trades at $70.4 (market cap $12.58B). The key difference: Tempus AI is far larger — about 2.4× GXO Logistics Inc's market cap, and Tempus AI is trading nearer its 52-week high, GXO Logistics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GXO Logistics Inc for 28 Days and Tempus AI for 22 Days on average.
| GXO | TEM | |
|---|---|---|
Market Cap | $5.32B | $12.58B |
Volume | 1,255,816 | 7,444,569 |
Sector | Industrials | Broad Market / Factor |
52-Week High | $65.59 | $99.28 |
52-Week Low | $44.17 | $41.55 |
Typical Hold Time | 28 Days | 22 Days |
Enterprise Value | $10.67B | $13.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GXO Logistics trades at $45.99, down 0.88% today, with neutral technical indicators showing support at $45 and resistance at $46. The company reported strong Q2 2026 earnings, beating estimates with $0.59 EPS versus $0.583 expected, and announced strategic partnerships including a 10-year logistics deal with Columbia Sportswear in Europe. Revenue growth remains steady at 3.4% organic growth in Q2, though margins face pressure.
Analyst consensus is strongly bullish with 16 buy ratings and a $66.67 price target, representing 45% upside potential. Key risks include margin compression from new business at lower profitability and competitive pressures in the logistics sector. The improving freight industry outlook and GXO's market leadership position support long-term growth prospects.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GXO Logistics Inc
GXO is the world's largest pure-play contract logistics provider. It offers cutting-edge supply chain solutions, including automated warehousing and fulfillment, for global blue-chip companies.
Read more on GXO →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
